Qinghua Xu
Canhelp Genomics, Hangzhou · China
Editorial leadership for Journal of Advanced Cytology
Research interests
- Cancer Research
- Microarray
- Mammography
- Radiofrequency Ablation
- Translational Research
- B Cell Lymphoma
- Germinal Center
Biography
Qinghua Xu is affiliated with Canhelp Genomics in Hangzhou, China, where his work focuses on cancer research, translational research, and advanced diagnostic methodologies including microarray analysis, B cell lymphoma, germinal center biology, radiofrequency ablation, and mammography. He is a member of the China Anti-Cancer Association and the Chinese Research Hospital Association. His most influential contribution is the clinical validation of a 90-gene expression test for tumor tissue of origin diagnosis, published in 2022 in a large-scale multicenter study of 1417 patients, which has been cited 20 times. Dr. Xu has been recognized for his professional excellence, receiving the Best Employee Award from bioMérieux China in both 2011 and 2013.
Selected publications
- Clinical validation of a 90-gene expression test for tumor tissue of origin diagnosis: a large-scale multicenter study of 1417 patients 2022 cited 20×
- Gene expression profiling for the diagnosis of multiple primary malignant tumors 2021 cited 18×
- Gene Expression Profiling For Diagnosis of Multiple Primary Malignant Tumors 2020
- Development and prospective validation of a multitarget urine RNA assay for noninvasive detection of urothelial carcinoma Recent 2025
- Gene Expression Profiling for the Diagnosis of Multiple Primary Malignant Tumors 2020
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JCY for your work?
This journal is guided by Qinghua Xu (Canhelp Genomics, Hangzhou) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.